StemRegenin1 (SR1) --- HSC Expansion Molecule
| Overview | |
| Catalog # | bs-60001c-2-mg-solid |
| Product Name | StemRegenin1 (SR1) --- HSC Expansion Molecule |
| Specifications | |
| Storage Buffer | Powder |
| Storage Condition | Store in dry, dark place at -20C for 1 year. |
| Target | |
| Product Information | Molecular Weight: 429.54 Formula: C24 H23 N5 O S CAS Number: 1227633-49-9 InChi Key: BGFHMYJZJZLMHW-UHFFFAOYSA-N InChi: InChI=1S/C24H23N5OS/c1-15(2)29-14-26-21-23(25-12-11-16-7-9-17(30)10-8-16)27-22(28-24(21)29)19-13-31-20-6-4-3-5-18(19)20/h3-10,13-15,30H,11-12H2,1-2H3,(H,25,27,28) Smiles: CC(C)N1C=NC2=C(NCCC3C=CC(O)=CC=3)N=C(N=C12)C1=CSC2=CC=CC=C21 Purity: 98.0 Solubility: DMSO up to 100 mM Appearance: Solid Power. Shelf Life: 1.0 years |
| Description | StemRegenin1 (SR1) is a selective, cell-permeable antagonist of aryl hydrocarbon receptor. It can promote robust expansion and self-renewal of human CD34+ peripheral blood and cord blood hematopoietic stem cells (HSCs, EC50 ~120 nM). SR1 expanded CD34+ cells from bone marrow of humans, monkeys and dogs, but not mice. Culture of HSCs with 1 µM SR1 for 21 days led to a 50-fold increase in cells expressing CD34 and a 17-fold increase in cells that retain the ability to engraft immunodeficient mice. Currently Novartis is conducting clinical trials, “LFU835-expanded Umbilical Cord Blood Hematopoietic Stem Cells in Patients With Hematological Malignancies”, related to this research. |
Powered by Bioz